Catalyst
Slingshot members are tracking this event:
Nuvectra (NVTR) Submitted Chemical Composition and Biocompatibility Data to FDA for Virtis in chronic urinary retention and symptoms of overactive bladder
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NVTR |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 18, 2019
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Virtis, Chronic Urinary Retention, Overactive Bladder
